Raymundo Paraná

Raymundo Paraná

Auto-generated profile, based on publicly available information

Raymundo Paraná


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Annals of Hepatology
Verified
Journal Article
Open access
JAJuan Pablo Arab
Juan Pablo Arab
MDMelisa Dirchwolf
Melisa Dirchwolf
MAMario Reis Alvares-da-Silva
Mario Reis Alvares-da-Silva
FBFrancisco Barrera
Francisco Barrera
CBCarlos Benítez
Carlos Benítez
MAMarco Arrese
Marco Arrese
Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitantly with the global epidemic of obesity, type 2 diabetes mellitus (T2DM), and sedentary lifestyle. NAFLD is a clinical syndrome that encompasses a wide spectrum of associated diseases and hepatic complications such as hepatocellular carcinoma (HCC). Moreover, this disease is believed to become the main indication for liver transplantation in the near future. Since NAFLD management represents a growing challenge for primary care physicians, the Asociación Latinoamericana para el Estudio del Hígado (ALEH) has decided to organize this Practice Guidance for the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease, written by Latin-American specialists in different clinical areas, and destined to general practitioners, internal medicine specialists, endocrinologists, diabetologists, gastroenterologists, and hepatologists. The main purpose of this document is to improve patient care and awareness of NAFLD. The information provided in this guidance may also be useful in assisting stakeholders in the decision-making process related to NAFLD. Since new evidence is constantly emerging on different aspects of the disease, updates to this guideline will be required in future.

1 October 2005 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
SVSebastião Viana
Sebastião Viana
RPRaymundo Paraná
Raymundo Paraná
RMRegina CélIa Moreira
Regina CélIa Moreira
ACAdriana Parise Compri
Adriana Parise Compri
VMVanise Macedo
Vanise Macedo
Severe cases of hepatitis caused by hepatitis B virus (HBV) or hepatitis D virus (HDV) are often seen in the Brazilian Amazon, but there is a paucity of epidemiologic studies on viral hepatitis in this area. Thus, a cross-sectional study to investigate the prevalence of markers for HBV and HDV was performed. Serum samples were collected after participants completed an epidemiologic questionnaire. Markers for HBV and HDV were analyzed with an enzyme-linked immunosorbent assay. The HBV genotype was determined by sequencing of the gene for hepatitis B surface antigen (HBsAg). Of 2,656 samples, 89 (3.3%) were positive for HBsAg and 1,628 (61.5%) were positive for IgG antibody to hepatitis B core antigen. Markers for HDV were found in 47 cases (1.7%). Antibodies to HDV were associated with Amerindian ethnic origin, a lower educational level, a history of acute viral hepatitis, a history of malaria, male sex, a history of tattooing, and older age. The most frequent HBV genotypes were A and F. This study showed a high prevalence of HBV and HDV in the western Brazilian Amazon, as well as the predominance of HBV genotypes A and F.

11 May 2006 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
CLCirley Lobato
Cirley Lobato
JTJosé Tavares‐Neto
José Tavares‐Neto
MRMárcio Rios‐Leite
Márcio Rios‐Leite
CTChristian Trepo
Christian Trepo
LVLudmila Vitvitski
Ludmila Vitvitski
RPRaymundo Paraná
Raymundo Paraná

1 December 2005 in Journal of Clinical Virology
Verified
Journal Article
Closed access
RPRaymundo Paraná
Raymundo Paraná
DADelvone Almeida
Delvone Almeida

1 July 1999 in Hepatology
Verified
Journal Article
Open access
PDF file
RPRaymundo Paraná
Raymundo Paraná
LVLudmila Vitvitski
Ludmila Vitvitski
ZAZilton Andrade
Zilton Andrade
CTChristian Trepo
Christian Trepo
HCHelma Cotrim
Helma Cotrim
LLLuis Lyra
Luis Lyra
In a 4-year follow-up study, patients with acute sporadic non-A, non-B (NANB) hepatitis were evaluated to determine the etiology and natural history of the disease. Acute hepatitis C virus (HCV) was detected in 13 of 43 (30%) of patients, anti-hepatitis E virus (HEV) IgG in 5 (12%), and 25 (58%) were considered non-A-E. The HCV RNA was detected in all HCV patients but none of the non-A-E cases. The initial clinical and biochemical presentation of the HCV and non-A-E cases was quite similar, although 2 of the non-A-E patients had severe disease. The 5 patients who were found to be anti-HEV IgG-reactive recovered within 6 months of follow-up. Of the 13 HCV cases, alanine transaminase (ALT) levels returned to normal in 7 (53.8%), while 6 (46.2%) continued to show abnormal ALT after 6 months of follow-up. However, 9 (69.2%) of them remained HCV-RNA-positive, denoting virological/biochemical dissociation. Long-term follow-up showed a reappearance of HCV RNA in 2 of the 4 patients who were in virological remission performing 84% of chronicity rate. Acute non-A-E hepatitis patients were less likely to evolve toward chronicity, as compared with acute HCV cases (16% vs. 84%; P = .0001). Only 4 (16%) of the non-A-E patients were hepatitis G virus (HGV)-RNA-positive. Concerning risk factors for acquiring parenterally transmitted viruses, tattooing was the only one that could be associated with HCV transmission (P = .002). No risk factors could be identified for putative non-A-E virus transmission. Liver biopsies performed for chronic HCV patients showed a variable degree of inflammation, while the non-A-E patients presented less severe histological disease.

12 October 2004 in Liver International
Verified
Journal Article
Closed access
PDF file
MSMaria I. Schinoni
Maria I. Schinoni
ZAZilton Andrade
Zilton Andrade
LFLuiz A.R. De Freitas
Luiz A.R. De Freitas
RORubem Oliveira
Rubem Oliveira
RPRaimundo Paraná
Raimundo Paraná